Terms: = Leukemia AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Prognosis
11 results:
1. Vitamin C enhances co-localization of novel TET1 nuclear bodies with both Cajal and PML bodies in colorectal cancer cells.
El Osmani N; Prévostel C; Picque Lasorsa L; El Harakeh M; Radwan Z; Mawlawi H; El Sabban M; Shirinian M; Dassouki Z
Epigenetics; 2024 Dec; 19(1):2337142. PubMed ID: 38583183
[TBL] [Abstract] [Full Text] [Related]
2. Neural crest-related NXPH1/α-NRXN signaling opposes neuroblastoma malignancy by inhibiting organotropic metastasis.
Fanlo L; Gómez-González S; Rozalén C; Pérez-Núñez I; Sangrador I; Tomás-Daza L; Gautier EL; Usieto S; Rebollo E; Vila-Ubach M; Carcaboso AM; Javierre BM; Celià-Terrassa T; Lavarino C; Martí E; Le Dréau G
Oncogene; 2023 Jul; 42(28):2218-2233. PubMed ID: 37301928
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
[TBL] [Abstract] [Full Text] [Related]
4. MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway.
You GR; Chang JT; Li YL; Huang CW; Tsai YL; Fan KH; Kang CJ; Huang SF; Chang PH; Cheng AJ
Cells; 2022 Sep; 11(18):. PubMed ID: 36139430
[TBL] [Abstract] [Full Text] [Related]
5. Promyelocytic leukemia protein (PML) and stem cells: from cancer to pluripotency.
Vogiatzoglou AP; Moretto F; Makkou M; Papamatheakis J; Kretsovali A
Int J Dev Biol; 2022; 66(1-2-3):85-95. PubMed ID: 34881785
[TBL] [Abstract] [Full Text] [Related]
6. Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency.
Han M; Napier CE; Frölich S; Teber E; Wong T; Noble JR; Choi EHY; Everett RD; Cesare AJ; Reddel RR
J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745338
[TBL] [Abstract] [Full Text] [Related]
7. Increased expression of phosphorylated nbs1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes.
Kefala M; Papageorgiou SG; Kontos CK; Economopoulou P; Tsanas A; Pappa V; Panayiotides IG; Gorgoulis VG; Patsouris E; Foukas PG
Leuk Res; 2013 Nov; 37(11):1576-82. PubMed ID: 24054861
[TBL] [Abstract] [Full Text] [Related]
8. Useful markers for detecting minimal residual disease in cases of neuroblastoma.
Ootsuka S; Asami S; Sasaki T; Yoshida Y; Nemoto N; Shichino H; Chin M; Mugishima H; Suzuki T
Biol Pharm Bull; 2008 Jun; 31(6):1071-4. PubMed ID: 18520032
[TBL] [Abstract] [Full Text] [Related]
9. Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures.
Serrano E; Lasa A; Perea G; Carnicer MJ; Brunet S; Aventín A; Sierra J; Nomdedéu JF
Acta Haematol; 2006; 116(2):77-89. PubMed ID: 16914901
[TBL] [Abstract] [Full Text] [Related]
10. Significance of survivin mRNA expression in prognosis of neuroblastoma.
Ito R; Asami S; Motohashi S; Ootsuka S; Yamaguchi Y; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2005 Apr; 28(4):565-8. PubMed ID: 15802787
[TBL] [Abstract] [Full Text] [Related]
11. T-cell prolymphocytic leukemia with autoimmune manifestations in Nijmegen breakage syndrome.
Michallet AS; Lesca G; Radford-Weiss I; Delarue R; Varet B; Buzyn A
Ann Hematol; 2003 Aug; 82(8):515-517. PubMed ID: 12845481
[TBL] [Abstract] [Full Text] [Related]
